A new peer-reviewed study, which came out of Europe, found that the vast majority of people who’ve had a previous COVID-19 infection have both robust and lasting protection from the virus. Specifically, it found that the vast majority of people will continue to carry antibodies against the virus for at least 12 months. Meanwhile, in…
Facts Matter (Oct. 23): Natural Antibodies Persist for More Than a Year After Infection: New Peer-Reviewed Study Finds
Antibodies Persist for More Than a Year After COVID-19 Infection, Study Finds
The immune systems of the vast majority of people who have been infected with the CCP virus will continue to carry antibodies against the virus for at least 12 months, according to a peer-reviewed study accepted by the European Journal of Immunology on Sept. 24. Scientists at the Finnish Institute for Health and Welfare studied the…
Vaccine Antibodies Decline 7 Months After Second Shot: US Study
Antibody levels generated by two shots of the Pfizer-BioNTech vaccine can undergo up to a 10-fold decrease seven months following the second vaccination, research suggests. The drop in antibody levels will compromise the body’s ability to defend itself against COVID-19 if the individual becomes infected. In a recent BioRxiv study published ahead of peer-review, many…
Alberta Evaluating Natural Immunity for Vaccine Passport Program
The Alberta government is looking into whether people with natural immunity against COVID-19 can qualify for its new vaccine passport, though it’s unlikely to be implemented soon. “We’re looking at that,” said Premier Jason Kenney during a live public question and answer session on Facebook on Sept. 17. He was answering a question about whether…
New Jersey Senator to Propose Bill to Treat Recovered COVID-19 Patients No Different Than Vaccinated People
Sen. Joe Pennacchio (R-N.J.) announced on Wednesday he would introduce new legislation that would treat recovered COVID-19 patients the same as those who have been vaccinated. The proposed measure will apply to any vaccine mandate or passport scheme that may be implemented, according to a statement by Pennacchio. The introduction of the bill addresses public…
New Jersey Lawmaker to Propose Bill to Treat Recovered COVID-19 Patients No Different Than Vaccinated People
New Jersey State Sen. Joe Pennacchio announced on Wednesday he would introduce new legislation that would treat recovered COVID-19 patients the same as those who have been vaccinated. The proposed measure will apply to any vaccine mandate or passport scheme that may be implemented, according to a statement by Pennacchio, a Republican. The introduction of…
Mayo Study Finds Antibody Treatment Can Help COVID-19 Patients
By Christopher Snowbeck From Star Tribune MINNEAPOLIS—A subset of COVID-19 patients who received infusions of laboratory-made antibodies ran a lower risk of requiring hospital care for their illnesses, according to a Mayo Clinic study released Monday. The report in the journal Lancet EClinical Medicine suggests that certain monoclonal antibody treatments can help patients with mild…
Why Is COVID-19 so Severe?
Are the antibodies we produce to fight COVID-19 infection causing severe disease? A new paper—so new in fact that it has not yet been peer-reviewed—from scientists in Hangzhou, China, appears to indicate just that. The researchers’ data suggests that at least two antibodies which target the spike protein that enables the COVID-19 virus to enter…
Why Is COVID-19 Severe for Some?
Are the antibodies we produce to fight COVID-19 infection causing severe disease? A new paper—so new in fact that it hasn’t yet been peer-reviewed—from scientists in Hangzhou, China, appears to indicate just that. The researchers’ data suggests that at least two antibodies that target the spike protein that enables the COVID-19 virus to enter human…
Why Is Covid so Severe?
Are the antibodies we produce to fight COVID infection causing severe disease? A new paper—so new in fact that it has not yet been peer-reviewed—from scientists in Hangzhou, China, appears to indicate just that. The researchers’ data suggests that at least two antibodies which target the spike protein that enables the COVID virus to enter…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`